Remove tag infant-health
article thumbnail

Grand Rounds September 22, 2023: Integrating Community Health Workers into Team-Based, Early Childhood Preventative Care (Tumaini Rucker Coker, MD, MBA)

Rethinking Clinical Trials

This may be the only interaction the family has with a healthcare professional, so if there are needs around behavior, health, social needs they will be addressed during these visits. Based on these findings, the research team initiated a larger PARENT trial that had 3 parent coaches at federally qualified health centers.

Trials 278
article thumbnail

Novartis’ $2 Million Gene Therapy Zolgensma Shows ‘Remarkable’ Results and Offers Hope for Children with SMA

XTalks

With a price tag of over $2.5 In England, five-month old baby Arthur became the country’s first SMA patient to receive the Zolgensma gene therapy last week through the National Health Service (NHS). They also advised use of Zolgensma for infants with SMA type 1 before they develop symptoms. Baby Arthur: First UK Patient.

article thumbnail

Roche takes on pricey rivals as FDA approves SMA drug

pharmaphorum

While this is not cheap by anybody’s reckoning, Roche hopes that the less intimidating price tag, plus the patient-friendly oral administration method will give it a competitive edge. Infants achieved the ability to sit without support for at least five seconds, a key motor milestone not normally seen in the natural course of the disease.